Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer

Back

10th Euro-Global Conference on Infectious Diseases

Rome, Italy

Vijaya Satchidanandam

Vijaya Satchidanandam

Indian Institue of Science, India

Title: Flavivirus vaccine: Molecular basis for attenuation of Live attenuated Japanese encephalitis virus vaccine SA14-14-2

Biography

Biography: Vijaya Satchidanandam

Abstract

Diseases caused by flaviviruses including Zika, dengue, Japanese encephalitis, West Nile encephalitis and yellow fever have become increasingly frequent over the last couple of decades, aided by global warming and expanding geographies of the mosquito vector. The extremely safe and efficacious WHO-certified live attenuated vaccine for Japanese encephalitis virus (JEV) SA-14-14-2 is used worldwide. We observed impressive enhancement in human CD8+ T cell responses in vaccines relative to volunteers naturally exposed to circulating strains of JEV. Using cell lines that support JEV infection, we queried the molecular basis underlying the generation of enhanced CD8+ T cells by the live vaccine SA-14-14-2. Our studies revealed that the vaccine virus induced severe ER stress, viral protein was rapidly degraded in vaccine virus-infected cells and was differentially recognized by a panel of monoclonal antibodies. Sustained activation of the ER stress sensor PERK in vaccine virus-infected cells led to prolonged phosphorylation of eIF2α, activation of autophagy markers and upregulation of ER chaperones in SA-14-14-2-infected cells. Interestingly, we also observed active dephosphorylation of eIF2α and inhibition of end stage autophagy in WT JEV infected cells. The mutated viral proteins responsible for these effects are being investigated. Our results can guide the rational design of efficacious vaccines against both flaviviruses such as Zika virus, dengue virus and West Nile virus and other pathogenic viruses belonging to other families.